Program
DLBS3233
Its studies are mostly in Diabetes Mellitus, Type 2 · Polycystic Ovary Syndrome · Prediabetic State, led by Dexa Medica Group.
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Dexa Medica Group | 60 open or running | phase 3since Nov 11, 2011 | Nov 11, 2011 | none ahead |
Also a collaborator on its studies: pt-equilab-international.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Nov 11, 2011First study: phase 3 study in Type-2 Diabetes MellitusFirst studyNCT01472614 · 54 enrolled · Indonesia
- Feb 9, 2012Phase 3 study in Diabetes Mellitus, Type 2NCT01531933 · 80 enrolled · Indonesia
- Jul 18, 2012Phase 3 study in Type-2-diabetes MellitusNCT01645332 · 104 enrolled · Indonesia
- Nov 21, 2012Phase 3 study in Polycystic Ovary SyndromeNCT01733459 · 124 enrolled · Indonesia
- Nov 26, 2013Phase 3 study in Polycystic Ovary SyndromeNCT01999686 · 186 enrolled · Indonesia
- Nov 9, 2026Phase 3 study in Prediabetic StateNCT07937449 · 120 enrolled · Indonesia
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 6 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07937449Prediabetic State · Indonesia | 3 | Completed | Oct 15, 2026 | 120 |
| NCT01999686Polycystic Ovary Syndrome · Indonesia | 3 | Completed | Feb 2019 | 186 |
| NCT01733459Polycystic Ovary Syndrome · Indonesia | 3 | Completed | Apr 2018 | 124 |
| NCT01645332Type-2-diabetes Mellitus · Indonesia | 3 | Completed | Aug 2014 | 104 |
| NCT01531933Diabetes Mellitus, Type 2 · Indonesia | 3 | Completed | Jul 2012 | 80 |
| NCT01472614Type-2 Diabetes Mellitus · Indonesia | 3 | Completed | Jan 2013 | 54 |
How it is read
Names in the registry
- “DLBS3233”, 6 entries
Conditions, from the studies’ own filings
- Diabetes Mellitus, Type 2, 3 studies
- Polycystic Ovary Syndrome, 2 studies
- Prediabetic State, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.